Global Follicular Lymphoma Therapeutic Market Research Report 2023

Report ID: 1975266 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Follicular Lymphoma Therapeutic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 ChemOthersapy
        1.2.3 RadiOthersapy
        1.2.4 Monoclonal Antibodies
        1.2.5 Stem Cell Transplantation
    1.3 Market by Application
        1.3.1 Global Follicular Lymphoma Therapeutic Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Follicular Lymphoma Therapeutic Market Perspective (2017-2028)
    2.2 Follicular Lymphoma Therapeutic Growth Trends by Region
        2.2.1 Follicular Lymphoma Therapeutic Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Follicular Lymphoma Therapeutic Historic Market Size by Region (2017-2022)
        2.2.3 Follicular Lymphoma Therapeutic Forecasted Market Size by Region (2023-2028)
    2.3 Follicular Lymphoma Therapeutic Market Dynamics
        2.3.1 Follicular Lymphoma Therapeutic Industry Trends
        2.3.2 Follicular Lymphoma Therapeutic Market Drivers
        2.3.3 Follicular Lymphoma Therapeutic Market Challenges
        2.3.4 Follicular Lymphoma Therapeutic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Follicular Lymphoma Therapeutic Players by Revenue
        3.1.1 Global Top Follicular Lymphoma Therapeutic Players by Revenue (2017-2022)
        3.1.2 Global Follicular Lymphoma Therapeutic Revenue Market Share by Players (2017-2022)
    3.2 Global Follicular Lymphoma Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Follicular Lymphoma Therapeutic Revenue
    3.4 Global Follicular Lymphoma Therapeutic Market Concentration Ratio
        3.4.1 Global Follicular Lymphoma Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Follicular Lymphoma Therapeutic Revenue in 2021
    3.5 Follicular Lymphoma Therapeutic Key Players Head office and Area Served
    3.6 Key Players Follicular Lymphoma Therapeutic Product Solution and Service
    3.7 Date of Enter into Follicular Lymphoma Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Follicular Lymphoma Therapeutic Breakdown Data by Type
    4.1 Global Follicular Lymphoma Therapeutic Historic Market Size by Type (2017-2022)
    4.2 Global Follicular Lymphoma Therapeutic Forecasted Market Size by Type (2023-2028)
5 Follicular Lymphoma Therapeutic Breakdown Data by Application
    5.1 Global Follicular Lymphoma Therapeutic Historic Market Size by Application (2017-2022)
    5.2 Global Follicular Lymphoma Therapeutic Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Follicular Lymphoma Therapeutic Market Size (2017-2028)
    6.2 North America Follicular Lymphoma Therapeutic Market Size by Country (2017-2022)
    6.3 North America Follicular Lymphoma Therapeutic Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Follicular Lymphoma Therapeutic Market Size (2017-2028)
    7.2 Europe Follicular Lymphoma Therapeutic Market Size by Country (2017-2022)
    7.3 Europe Follicular Lymphoma Therapeutic Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Follicular Lymphoma Therapeutic Market Size (2017-2028)
    8.2 Asia-Pacific Follicular Lymphoma Therapeutic Market Size by Country (2017-2022)
    8.3 Asia-Pacific Follicular Lymphoma Therapeutic Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Follicular Lymphoma Therapeutic Market Size (2017-2028)
    9.2 Latin America Follicular Lymphoma Therapeutic Market Size by Country (2017-2022)
    9.3 Latin America Follicular Lymphoma Therapeutic Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Follicular Lymphoma Therapeutic Market Size (2017-2028)
    10.2 Middle East & Africa Follicular Lymphoma Therapeutic Market Size by Country (2017-2022)
    10.3 Middle East & Africa Follicular Lymphoma Therapeutic Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Detail
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Follicular Lymphoma Therapeutic Introduction
        11.1.4 Bayer Revenue in Follicular Lymphoma Therapeutic Business (2017-2022)
        11.1.5 Bayer Recent Development
    11.2 Biogen
        11.2.1 Biogen Company Detail
        11.2.2 Biogen Business Overview
        11.2.3 Biogen Follicular Lymphoma Therapeutic Introduction
        11.2.4 Biogen Revenue in Follicular Lymphoma Therapeutic Business (2017-2022)
        11.2.5 Biogen Recent Development
    11.3 F. Hoffmann-La Roche
        11.3.1 F. Hoffmann-La Roche Company Detail
        11.3.2 F. Hoffmann-La Roche Business Overview
        11.3.3 F. Hoffmann-La Roche Follicular Lymphoma Therapeutic Introduction
        11.3.4 F. Hoffmann-La Roche Revenue in Follicular Lymphoma Therapeutic Business (2017-2022)
        11.3.5 F. Hoffmann-La Roche Recent Development
    11.4 Gilead
        11.4.1 Gilead Company Detail
        11.4.2 Gilead Business Overview
        11.4.3 Gilead Follicular Lymphoma Therapeutic Introduction
        11.4.4 Gilead Revenue in Follicular Lymphoma Therapeutic Business (2017-2022)
        11.4.5 Gilead Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Follicular Lymphoma Therapeutic Introduction
        11.5.4 Merck Revenue in Follicular Lymphoma Therapeutic Business (2017-2022)
        11.5.5 Merck Recent Development
    11.6 Celldex
        11.6.1 Celldex Company Detail
        11.6.2 Celldex Business Overview
        11.6.3 Celldex Follicular Lymphoma Therapeutic Introduction
        11.6.4 Celldex Revenue in Follicular Lymphoma Therapeutic Business (2017-2022)
        11.6.5 Celldex Recent Development
    11.7 Boehringer Ingelheim
        11.7.1 Boehringer Ingelheim Company Detail
        11.7.2 Boehringer Ingelheim Business Overview
        11.7.3 Boehringer Ingelheim Follicular Lymphoma Therapeutic Introduction
        11.7.4 Boehringer Ingelheim Revenue in Follicular Lymphoma Therapeutic Business (2017-2022)
        11.7.5 Boehringer Ingelheim Recent Development
    11.8 Bristol-Myers Squibb
        11.8.1 Bristol-Myers Squibb Company Detail
        11.8.2 Bristol-Myers Squibb Business Overview
        11.8.3 Bristol-Myers Squibb Follicular Lymphoma Therapeutic Introduction
        11.8.4 Bristol-Myers Squibb Revenue in Follicular Lymphoma Therapeutic Business (2017-2022)
        11.8.5 Bristol-Myers Squibb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Follicular Lymphoma Therapeutic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of ChemOthersapy
    Table 3. Key Players of RadiOthersapy
    Table 4. Key Players of Monoclonal Antibodies
    Table 5. Key Players of Stem Cell Transplantation
    Table 6. Global Follicular Lymphoma Therapeutic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Follicular Lymphoma Therapeutic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Follicular Lymphoma Therapeutic Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Follicular Lymphoma Therapeutic Market Share by Region (2017-2022)
    Table 10. Global Follicular Lymphoma Therapeutic Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Follicular Lymphoma Therapeutic Market Share by Region (2023-2028)
    Table 12. Follicular Lymphoma Therapeutic Market Trends
    Table 13. Follicular Lymphoma Therapeutic Market Drivers
    Table 14. Follicular Lymphoma Therapeutic Market Challenges
    Table 15. Follicular Lymphoma Therapeutic Market Restraints
    Table 16. Global Follicular Lymphoma Therapeutic Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Follicular Lymphoma Therapeutic Market Share by Players (2017-2022)
    Table 18. Global Top Follicular Lymphoma Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicular Lymphoma Therapeutic as of 2021)
    Table 19. Ranking of Global Top Follicular Lymphoma Therapeutic Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Follicular Lymphoma Therapeutic Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Follicular Lymphoma Therapeutic Product Solution and Service
    Table 23. Date of Enter into Follicular Lymphoma Therapeutic Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Follicular Lymphoma Therapeutic Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Follicular Lymphoma Therapeutic Revenue Market Share by Type (2017-2022)
    Table 27. Global Follicular Lymphoma Therapeutic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Follicular Lymphoma Therapeutic Revenue Market Share by Type (2023-2028)
    Table 29. Global Follicular Lymphoma Therapeutic Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Follicular Lymphoma Therapeutic Revenue Market Share by Application (2017-2022)
    Table 31. Global Follicular Lymphoma Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Follicular Lymphoma Therapeutic Revenue Market Share by Application (2023-2028)
    Table 33. North America Follicular Lymphoma Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Follicular Lymphoma Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Follicular Lymphoma Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Follicular Lymphoma Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Follicular Lymphoma Therapeutic Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Follicular Lymphoma Therapeutic Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Follicular Lymphoma Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Follicular Lymphoma Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Follicular Lymphoma Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Follicular Lymphoma Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Bayer Company Detail
    Table 44. Bayer Business Overview
    Table 45. Bayer Follicular Lymphoma Therapeutic Product
    Table 46. Bayer Revenue in Follicular Lymphoma Therapeutic Business (2017-2022) & (US$ Million)
    Table 47. Bayer Recent Development
    Table 48. Biogen Company Detail
    Table 49. Biogen Business Overview
    Table 50. Biogen Follicular Lymphoma Therapeutic Product
    Table 51. Biogen Revenue in Follicular Lymphoma Therapeutic Business (2017-2022) & (US$ Million)
    Table 52. Biogen Recent Development
    Table 53. F. Hoffmann-La Roche Company Detail
    Table 54. F. Hoffmann-La Roche Business Overview
    Table 55. F. Hoffmann-La Roche Follicular Lymphoma Therapeutic Product
    Table 56. F. Hoffmann-La Roche Revenue in Follicular Lymphoma Therapeutic Business (2017-2022) & (US$ Million)
    Table 57. F. Hoffmann-La Roche Recent Development
    Table 58. Gilead Company Detail
    Table 59. Gilead Business Overview
    Table 60. Gilead Follicular Lymphoma Therapeutic Product
    Table 61. Gilead Revenue in Follicular Lymphoma Therapeutic Business (2017-2022) & (US$ Million)
    Table 62. Gilead Recent Development
    Table 63. Merck Company Detail
    Table 64. Merck Business Overview
    Table 65. Merck Follicular Lymphoma Therapeutic Product
    Table 66. Merck Revenue in Follicular Lymphoma Therapeutic Business (2017-2022) & (US$ Million)
    Table 67. Merck Recent Development
    Table 68. Celldex Company Detail
    Table 69. Celldex Business Overview
    Table 70. Celldex Follicular Lymphoma Therapeutic Product
    Table 71. Celldex Revenue in Follicular Lymphoma Therapeutic Business (2017-2022) & (US$ Million)
    Table 72. Celldex Recent Development
    Table 73. Boehringer Ingelheim Company Detail
    Table 74. Boehringer Ingelheim Business Overview
    Table 75. Boehringer Ingelheim Follicular Lymphoma Therapeutic Product
    Table 76. Boehringer Ingelheim Revenue in Follicular Lymphoma Therapeutic Business (2017-2022) & (US$ Million)
    Table 77. Boehringer Ingelheim Recent Development
    Table 78. Bristol-Myers Squibb Company Detail
    Table 79. Bristol-Myers Squibb Business Overview
    Table 80. Bristol-Myers Squibb Follicular Lymphoma Therapeutic Product
    Table 81. Bristol-Myers Squibb Revenue in Follicular Lymphoma Therapeutic Business (2017-2022) & (US$ Million)
    Table 82. Bristol-Myers Squibb Recent Development
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Follicular Lymphoma Therapeutic Market Share by Type: 2021 VS 2028
    Figure 2. ChemOthersapy Features
    Figure 3. RadiOthersapy Features
    Figure 4. Monoclonal Antibodies Features
    Figure 5. Stem Cell Transplantation Features
    Figure 6. Global Follicular Lymphoma Therapeutic Market Share by Application in 2021 & 2028
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Others Case Studies
    Figure 10. Follicular Lymphoma Therapeutic Report Years Considered
    Figure 11. Global Follicular Lymphoma Therapeutic Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Follicular Lymphoma Therapeutic Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Follicular Lymphoma Therapeutic Market Share by Region: 2021 VS 2028
    Figure 14. Global Follicular Lymphoma Therapeutic Market Share by Players in 2021
    Figure 15. Global Top Follicular Lymphoma Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicular Lymphoma Therapeutic as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Follicular Lymphoma Therapeutic Revenue in 2021
    Figure 17. North America Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Follicular Lymphoma Therapeutic Market Share by Country (2017-2028)
    Figure 19. United States Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Follicular Lymphoma Therapeutic Market Share by Country (2017-2028)
    Figure 23. Germany Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Follicular Lymphoma Therapeutic Market Share by Region (2017-2028)
    Figure 31. China Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Follicular Lymphoma Therapeutic Market Share by Country (2017-2028)
    Figure 39. Mexico Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Follicular Lymphoma Therapeutic Market Share by Country (2017-2028)
    Figure 43. Turkey Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Follicular Lymphoma Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Bayer Revenue Growth Rate in Follicular Lymphoma Therapeutic Business (2017-2022)
    Figure 46. Biogen Revenue Growth Rate in Follicular Lymphoma Therapeutic Business (2017-2022)
    Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Follicular Lymphoma Therapeutic Business (2017-2022)
    Figure 48. Gilead Revenue Growth Rate in Follicular Lymphoma Therapeutic Business (2017-2022)
    Figure 49. Merck Revenue Growth Rate in Follicular Lymphoma Therapeutic Business (2017-2022)
    Figure 50. Celldex Revenue Growth Rate in Follicular Lymphoma Therapeutic Business (2017-2022)
    Figure 51. Boehringer Ingelheim Revenue Growth Rate in Follicular Lymphoma Therapeutic Business (2017-2022)
    Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Follicular Lymphoma Therapeutic Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Biogen
F. Hoffmann-La Roche
Gilead
Merck
Celldex
Boehringer Ingelheim
Bristol-Myers Squibb
Frequently Asked Questions
Follicular Lymphoma Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Follicular Lymphoma Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Follicular Lymphoma Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Portable Power Tools

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More